Nirsevimab is the first investigational long-acting antibody designed for all infants to help protect against respiratory syncytial virus (RSV) throughout their first RSV season with a single dose Health Canada has accepted… Read More
OTTAWA, ON — BioTalent Canada today announced the recipients of its inaugural I.D.E.A.L. Bioscience Employer™ designation. The I.D.E.A.L. Recognition Program recognizes organizations in the Canadian bio-economy who embody the principles of… Read More
Sonic Incytes Medical Corp. is pleased to announce its project was selected for investment by the inaugural INOVAIT Focus Fund. INOVAIT is a pan-Canadian network funded by the Government of… Read More
VANCOUVER, BC — (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to… Read More
Northview would like to congratulate Neovasc Inc. on their approximately US $100 million transaction with Shockwave Medical. Neovasc is a minimally invasive cardiac device company focusing on the treatment of… Read More
